Skip to main content

Table 1 Characteristics of 66 Pediatric Participants Receiving Isoniazid Preventive Therapy

From: Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania

Characteristic

Total (n = 66) n (%)

Summary Statistic

Sex

 Female

43 (65.1)

 

Age at Initiation, median (Q1, Q3)1

 

11 (8, 13)

 0–5 years

6 (9.1)

 

 6–10 years

21 (31.8)

 

 11–15 years

39 (59.1)

 

WHO Clinical Staging for HIV at Initiation

 I

3 (4.5)

 

 II

26 (39.4)

 

 III

33 (50.0)

 

 IV

3 (4.5)

 

 Missing or not reported

1 (1.5)

 

History of Tuberculosis

 Yes

12 (18.2)

 

 No

54 (81.8)

 

ART Status

 On ART

66 (100.0)

 

 Duration of ART at initiation in years, median (Q1, Q3)

 

5 (2.25, 8)

History of Liver Disease

 Yes

0 (0.0)

 

 No

57 (86.4)

 

 Missing or not reported

9 (13.6)

 
  1. 1(First Quartile, Third Quartile)